Stocks TelegraphStocks Telegraph
Stock Ideas

TFX Company Profile and Key Details

NYSE : TFX

Teleflex

$130.35
-3.19-2.39%
At Close 4:00 PM
55.41
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Teleflex Incorporated (TFX) stock declined over -2.39%, trading at $130.35 on NYSE, down from the previous close of $133.54. The stock opened at $131.84, fluctuating between $129.60 and $132.02 in the recent session.

Stock Snapshot

133.54
Prev. Close
5.77B
Market Cap
129.595
Day Low
12.16
P/E Ratio
10.72
EPS (TTM)
8.92
Cash Flow per Share
131.84
Open
44.27M
Number of Shares
132.02
Day High
99.64%
Free Float in %
94.49
Book Value
224.55K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 08, 2026132.34132.34129.60130.35267.28K
Jul 07, 2026135.41136.69133.19133.54478.95K
Jul 06, 2026134.76135.28132.37134.32435.02K
Jul 02, 2026131.70134.53128.26133.99673.2K
Jul 01, 2026127.75130.94127.75129.75427.23K
Jun 30, 2026126.94127.60124.88126.76355.24K
Jun 29, 2026129.13129.13126.50127.49398.96K
Jun 26, 2026126.76131.64126.76129.86602.44K
Jun 25, 2026127.15129.93125.99127.79310.3K
Jun 24, 2026124.77127.61124.77126.51267.73K
Jun 23, 2026121.21124.70121.21124.26407.23K
Jun 22, 2026126.43126.43120.86121.67722.67K
Jun 18, 2026125.50127.30124.29127.00557.45K
Jun 17, 2026126.58129.19124.06124.96427.1K
Jun 16, 2026130.00130.07126.55127.87426.44K
Jun 15, 2026130.98132.39128.85130.09437.43K
Jun 12, 2026128.82132.24127.61130.48391.27K
Jun 11, 2026131.75132.36128.93129.31549.27K
Jun 10, 2026134.67136.59132.04132.15517K
Jun 09, 2026132.35136.15131.90135.75579.53K

Contact Details

Wayne, PA 19087-1603

United States

https://www.teleflex.com610 225 6800

About Company

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Company Information

Employees14100
Beta0.82
Sales or Revenue$2.97B
5Y Sales Change%0.181%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Instruments & Supplies

Company Overview

Teleflex Incorporated (NYSE:TFX) closed at $130.35 USD, losing -$3.19 (-2.39%) from the previous close of $133.54. The stock is currently mid-range between its 52-week high and low $100.18 and $139.67. With a market capitalization of about $5.77 billion, Teleflex Incorporated is classified as a mid-cap and shows market-like volatility (beta ~0.82). Key stats such as the average daily volume over the past year has been around 733.71 thousand shares, volume is running light vs its 52-week average. Headquartered in Wayne, PA, Teleflex Incorporated operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Stuart A. Randle, the company employs approximately 14,100 people and listed since March 17, 1980. Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices.

Technical Performance

TFX has shown weak momentum, losing -7.57% over the past week and -21.69% over the past quarter, though year-to-date performance is down -17.78%. Short-term trend indicators are bullishly aligned (SMA20 10.07%, SMA50 6.07%, SMA200 0.11%). The stock’s 14-day RSI is 65.25 (firm momentum), while the ATR of 4.7 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -33.36% below its high and over 18.94% above its low. Average 10-day trading volume of 433.70 thousand shares is below the 3-month average of 715.74 thousand, indicating normal recent market interest.

Valuation Metrics

Teleflex Incorporated trades at a P/E ratio of -5.71, slightly below the S&P 500 average, with a price-to-sales ratio of 2.05 and a price-to-book ratio of 1.87 suggesting the stock is closer to book value. The P/FCF stands at 23.13, also above market averages.

Dividend & Fair Value

Teleflex Incorporated last paid a dividend of 1.36 per share, this equals a trailing yield of roughly 0.59%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $110.93. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Teleflex Incorporated generated EPS of -$7.36 over the past year. Five-year average earnings growth is -31.49%. Wall Street analysts project EPS growth of 2.21% annually over the next five years. The latest quarter delivered EPS of $1.39. The next quarter is forecast at $3.74. Next year's EPS is expected at $3.43. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 2 Buy ratings, 15 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $114.00. The high target offers 22.75% upside. The low target suggests -12.54% downside. The mean target is $133.45. This offers 2.38% upside. Teleflex Incorporated earnings surprise history is a mixed track record. The quarter that ended May 07, 2026, missed forecasts by 14.88%. The prior quarter beat by -48.26%. Over the last six quarters, Apple has recorded several small beats. These include 0.78% in February 27, 2025.

Shareholding & Insider Activity

Teleflex Incorporated has 44.19 million shares outstanding. The public float is 44.03 million shares, elevated short interest at 3.41% of float. This equals 935.70 thousand shares. The short ratio is 1.6 days. Institutional investors hold 112.37% of the float. Insiders own 0.47%. SMITH BENSON holds 48.81 thousand shares, Kelly Liam has 45.27 thousand shares and Leyden James J has 15.89 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Teleflex generated $2.97B in revenue, or $62.88 per share. Gross margin was 55.37%, operating margin 17.02%, and net profit margin 11.98%. Returns are modest, with ROA at 4.73% and ROE at 8.02%.
On valuation metrics, Teleflex trades at a P/E of -5.71, P/S of 2.05 and P/B of 1.87. The current ratio is 2.55 and quick ratio is 2.03. Operationally, the company’s inventory turnover is 3.45 and cash conversion cycle is 113.38 days. Debt-to-equity is 0.87, supported by a cash flow-to-debt ratio of 0.12.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Teleflex posted revenue of $2.97B, down slightly from $2.79B in the prior quarter. Gross profit was $1.65B (margin 55.37%). Operating income was $506.31M (margin 17.0%). Net income was$356.33M (EPS $7.58).
The company ended the quarter with $222.85M in cash and short-term investments, a total debt of $1.93B, and net debt of $1.70B. Total assets were $7.53B, with equity of $4.44B. Financials further reflected stability, with operating cash flow of $510.64M, free cash flow of $419.20M, and capital expenditures of - $91.44M.

Frequently Asked Questions

What is the current Teleflex Incorporated (TFX) stock price?
Teleflex Incorporated (NYSE: TFX) stock price is $130.35 in the last trading session. During the trading session, TFX stock reached the peak price of $132.02 while $129.60 was the lowest point it dropped to. The percentage change in TFX stock occurred in the recent session was -2.39% while the dollar amount for the price change in TFX stock was - $3.19.
TFX's industry and sector of operation?
The NYSE listed TFX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Teleflex Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of TFX?
Ms. Michelle Fox
Corporation Vice President & Chief Medical Officer
Mr. Howard Cyr
Corporation Vice President & Chief Compliance Officer
Mr. Jay White
Corporation Vice President & Pres of Global Commercial
Mr. Cameron P. Hicks
Corporation Vice President of HR & Communications
Mr. Daniel V. Logue
Corporation Vice President, Gen. Counsel & Sec.
Mr. Liam J. Kelly
Chairman, Pres & Chief Executive Officer
Mr. Thomas E. Powell
Executive Vice President & Chief Financial Officer
Mr. John Hsu C.F.A.
Vice President of Investor Relations
Mr. James P. Winters
Corporation Vice President, Manufacturing and Supply Chain
Mr. John R. Deren
Corporation Vice President & Chief Accounting Officer
Mr. Matt Tomkin
Vice President of Corporation Devel.
Mr. Timothy F. Duffy
Vice President & Chief Information Officer
How TFX did perform over past 52-week?
TFX's closing price is 30.12% higher than its 52-week low of $100.18 where as its distance from 52-week high of $139.67 is -6.67%.
How many employees does TFX have?
Number of TFX employees currently stands at 14,100.
Link for TFX official website?
Official Website of TFX is: https://www.teleflex.com
How do I contact TFX?
TFX could be contacted at phone 610 225 6800 and can also be accessed through its website. TFX operates from 550 East Swedesford Road, Wayne, PA 19087-1603, United States.
How many shares of TFX are traded daily?
TFX stock volume for the day was 224.55K shares. The average number of TFX shares traded daily for last 3 months was 733.71K.
What is the market cap of TFX currently?
The market value of TFX currently stands at $5.77B with its latest stock price at $130.35 and 44.27M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph